Article Information
PubMed
Published By
History
- Received June 15, 2018
- Revision received January 18, 2019
- Accepted February 1, 2019
- Published online February 14, 2019.
Copyright & Usage
Copyright © 2019 Blair et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Laura J. Blair1,
- Marangelie Criado-Marrero1,
- Dali Zheng1,
- Xinming Wang2,
- Siddharth Kamath1,
- Bryce A. Nordhues1,
- Edwin J. Weeber2 and
- Chad A. Dickey1,§
- 1Department of Molecular Medicine, University of South Florida, Byrd Institute, Tampa, FL 33613
- 2Department of Pharmacology and Physiology, University of South Florida, Byrd Institute, Tampa, FL 33613
- Correspondence should be addressed to Laura J. Blair at lblair{at}health.usf.edu.
Author contributions
Author contributions: L.J.B., E.J.W., and C.A.D. designed research; L.J.B., M.C.-M., D.Z., X.W., S.K., and B.A.N. performed research; L.J.B., M.C.-M., D.Z., X.W., S.K., and B.A.N. analyzed data; L.J.B. and C.A.D. wrote the paper.
Disclosures
C.A.D. and L.J.B. are the co-inventors for the following patent application: “Transgenic mouse model for conditional fkbp51 expression and related methods.” US Patent Application# US20150327523 A1. All other authors declare no competing financial interests.
This work was funded by the National Institute of Mental Health Grant 1R01MH103848 and the National Institute of Neurological Disorders and Stroke Grant R01NS073899.
↵§ Deceased, November 26, 2016.
Funding
HHS | NIH | National Institute of Mental Health (NIMH)
1R01MH103848HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
R01NS073899
Other Version
- You are viewing the most recent version of this article.
- previous version (February 14, 2019).
Online Impact